pancreatic cancer

Videos

High Costs of Pancreatic Enzyme Replacement Therapy Barrier to Medicare Beneficiary Drug Access

01/20/2021

Arjun Gupta, MD, discusses results from a study assessing out-of-pocket and total spending on pancreatic enzyme replacement therapy under Medicare Part D.

Arjun Gupta, MD, discusses...

01/20/2021

Journal of Clinical Pathways

Guideline Updates

AGA Updates Clinical Practice Guideline for Pancreatic Cancer Screening

06/29/2020

Individuals at high risk for pancreatic cancer should at minimum be considered for screening for the disease, according to a new clinical practice update from the American Gastroenterological Association

Individuals at high risk for...

06/29/2020

Journal of Clinical Pathways

Research in Review

Pancreatic Cancer Guidelines Do Not Cover Some Targetable Mutations

08/11/2017

JCP Editors

Germline mutations in pancreatic cancer susceptibility genes are often identified in patients with pancreatic cancer without a known family history of cancer, according to a recent study. ----- Related...

...

08/11/2017

Journal of Clinical Pathways

Research in Review

Combined Chemotherapy, Radiation Improves Survival in Locally Advanced Pancreatic Cancer

06/03/2017

JCP Editors

The addition of radiation therapy to chemotherapy improved overall survival (OS) in patients with unresected locally advanced pancreatic cancer, according to research presented at the 2017 ASCO Annual Meeting (June...

The...

06/03/2017

Journal of Clinical Pathways

Research in Review

Novel Therapy Plus Gemcitabine Does Not Improve OS in Pancreatic Cancer

04/11/2017

JCP Editors

A new tyrosine kinase inhibitor (TKI) in combination with gemcitabine does not improve overall survival (OS) any more than gemcitabine alone for patients with advanced pancreatic cancer, according to research...

A new...

04/11/2017

Journal of Clinical Pathways

Research in Review

Novel TKI Therapy Plus Gemcitabine Does Not Improve OS in Pancreatic Cancer

03/09/2017

JCP Editors

A new...

03/09/2017

Journal of Clinical Pathways

Treatment Protocol for Pancreatic Cancer May Improve Survival

05/28/2016

JCP Editors

Patients with pancreatic cancer formally believed to not be eligible for surgery may in fact benefit from resection, according to findings from two recent studies.   Pancreatic cancer can be an especially...

...

05/28/2016

Journal of Clinical Pathways

Research in Review

Clinical Pathway for Borderline Resectable Pancreatic Cancer Improves Survival

02/16/2016

JCP Editors

A clinical pathway developed by South Florida researchers may help to improve clinical outcomes for patients with borderline resectable pancreatic cancer.  Although rare, pancreatic cancer is still the...

...

02/16/2016

Journal of Clinical Pathways